Ontario Expands Drug List for Optometrists

Ontario Expands Drug List for Optometrists

Tuesday, February 7 2017 | 00 h 00 min | Press Release

The Ontario government has announced the expansion of the list of drugs that Optometrists can prescribe. An additional 11 drugs have been added to the list including specific topical corticosteroids and non-steroidal anti-inflammatory agents. Notably cyclosporine (brand name Restasis® Allergan), a topical immunomodulator indicated to increase tear production, is among the newly added drugs.

Click for the statement from the College of Optometrists of Ontario :

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Ontario Expands Drug List for Optometrists

Featured Posts